Arteriosclerosis Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Arteriosclerosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/761191/Arteriosclerosis-Global-Clinical-Trials-Review-H2-2014.html

Arteriosclerosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Arteriosclerosis Global Clinical Trials Review, H2, 2014" provides data on the Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arteriosclerosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Arteriosclerosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Arteriosclerosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Arteriosclerosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Arteriosclerosis 25
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Arteriosclerosis Therapeutics Clinical Trials 34
Prominent Drugs 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Merck & Co., Inc. 36
Clinical Trial Overview of Merck & Co., Inc. 36
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
F. Hoffmann-La Roche Ltd. 46
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 46
Sanofi 47
Clinical Trial Overview of Sanofi 47
Bristol-Myers Squibb Company 48
Clinical Trial Overview of Bristol-Myers Squibb Company 48
Eli Lilly and Company 49
Clinical Trial Overview of Eli Lilly and Company 49
Daiichi Sankyo Company, Limited 50
Clinical Trial Overview of Daiichi Sankyo Company, Limited 50
Clinical Trial Overview of Top Institutes / Government 51
National Heart, Lung, and Blood Institute 51
Clinical Trial Overview of National Heart, Lung, and Blood Institute 51
Brigham and Women's Hospital 57
Clinical Trial Overview of Brigham and Women's Hospital 57
Korea University 58
Clinical Trial Overview of Korea University 58
Johns Hopkins University 59
Clinical Trial Overview of Johns Hopkins University 59
National Institute on Aging 60
Clinical Trial Overview of National Institute on Aging 60
Mayo Clinic 61
Clinical Trial Overview of Mayo Clinic 61
Tehran University of Medical Sciences 62
Clinical Trial Overview of Tehran University of Medical Sciences 62
National Defense Medical College 63
Clinical Trial Overview of National Defense Medical College 63
University of California, San Francisco 64
Clinical Trial Overview of University of California, San Francisco 64
Maastricht University Medical Center 65
Clinical Trial Overview of Maastricht University Medical Center 65
Five Key Clinical Profiles 66
Appendix 132
Abbreviations 132
Definitions 132
Research Methodology 133
Secondary Research 133
About GlobalData 134
Contact Us 134
Disclaimer 134
Source 134

List of Tables
Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Arteriosclerosis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Arteriosclerosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Arteriosclerosis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 32
Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 36
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 39
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 41
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 43
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 45
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 46
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 47
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 48
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 49
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 50
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 51
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 57
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014* 58
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 59
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014* 60
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 61
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 62
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Defense Medical College, 2014* 63
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 64
Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 65

List of Figures
Arteriosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 32
Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
GlobalData Methodology 133


Read the full report:
Arteriosclerosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/761191/Arteriosclerosis-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer